Back to Companies

Invivyd

Detroit, US Biotechnology, Biopharmaceuticals, Life Sciences 141

Jobs at Invivyd

17 Open Positions

Senior Virology Care Specialist, Washington, D.C. at Invivyd

$120,000 - $160,000 Washington, D.C. Remote (City)

4 days ago

Senior Virology Care Specialist, Richmond at Invivyd

$120,000 - $160,000 Richmond Remote (City)

8 days ago

Senior Virology Care Specialist, Austin at Invivyd

$120,000 - $160,000 Austin Remote (City)

9 days ago

Strategic Account Manager, Boston at Invivyd

$152,000 - $202,000 Boston Remote (City)

9 days ago

Vice President, Associate General Counsel, Infectious Disease Franchise at Invivyd

$309,000 - $383,000 New Haven Hybrid

12 days ago

Director/Senior Director, Biostatistics at Invivyd

$184,000 - $245,000, $220,000 - $293,000 New Haven Remote (City)

12 days ago

Senior Director, Advertising and Promotion at Invivyd

$220,000 - $293,000 New Haven Hybrid

12 days ago

Manager, Regulatory at Invivyd

$120,000 - $160,000 New Haven Hybrid

12 days ago

Strategic Account Manager, El Paso at Invivyd

$152,000 - $202,000 El Paso Remote (Country)

19 days ago

Senior Virology Care Specialist at Invivyd

$120,000 - $160,000 Poughkeepsie Hybrid

24 days ago

Strategic Account Manager, Seattle at Invivyd

$152,000 - $202,000 Seattle On-site

25 days ago

Senior Virology Care Specialist, Columbus at Invivyd

Columbus Remote (City)

a month ago

No longer available

Regional Sales Director, Southeast at Invivyd

a month ago

No longer available

Associate Director, Drug Product Manufacturing and Development at Invivyd

USD 152,000 - 202,000 Yearly New Haven, Connecticut, United States On-site

2 months ago

No longer available

Field Reimbursement Manager at Invivyd

USD 152,000 - 202,000 Yearly United States Remote (Country)

2 months ago

About Invivyd

Invivyd develops and delivers protection from serious viral infectious diseases, beginning with SARS-CoV-2, using a proprietary integrated technology platform to assess, monitor, develop, and adapt best-in-class antibodies. The company received FDA emergency use authorization for a monoclonal antibody and is advancing a clinical program for VYD2311, a vaccine alternative monoclonal antibody for the prevention of COVID-19.

Links